Journal of Rheumatic Diseases

Quick links

· Most Cited · Most Read · On-line First · Archives · Go to e-Submission

Editorial Board

May, 2024~Present
May, 2022~May, 2024
May, 2020~May, 2022

Editor-in-Chief

Editor-in-Chief
Min-Chan Park, M.D., Ph.D.	Internal Medicine, Yonsei University, Seoul, Korea

Deputy Editor

Deputy Editor
Soo-Kyung Cho, M.D., Ph.D.	Internal Medicine, Hanyang University, Seoul, Korea

Associate Editor

Associate Editor
Young Ho Lee, M.D., Ph.D.	Internal Medicine, Korea University, Seoul, Korea
Seong-Kyu Kim, M.D., Ph.D.	Internal Medicine, Daegu Catholic University, Daegu, Korea
Soo-Young Lee, M.D., Ph.D.	Pediatrics, The Catholic University of Korea, Seoul, Korea
Sang-Won Lee, M.D., Ph.D.	Internal Medicine, Yonsei University, Seoul, Korea
Joong Kyong Ahn, M.D., Ph.D.	Internal Medicine, Sungkyunkwan University, Seoul, Korea
Seungwoo Han, M.D., Ph.D.	Internal Medicine, Kyungpook National University hospital, Daegu, Korea
Jin Kyun Park, M.D., Ph.D.	Internal Medicine, Seoul National University, Seoul, Korea

Ethics Editor

Ethics Editor
Im Hee Shin, Ph.D.	Medical Statistics, Daegu Catholic University, Daegu, Korea

Statistics Editor

Statistics Editor
Hyonggin An, Ph.D.	Biostatistics, Korea University, Seoul, Korea

Editorial Board

Editorial Board
Tatsuya Atsumi, M.D., Ph.D.	Rheumatology, Endocrinology and Nephrology, Hokkaido University, Sapporo, Japan
Matt Brown, M.D	Medical & Molecular Genetics, King’s College London, London, UK
Hyon K Choi, M.D.	Internal Medicine, Harvard Medical School, Massachusetts, USA
Robert D. Inman, B.A., M.D.	Immunology, Toronto University, Toronto, Canada
Seokchan Hong, M.D., Ph.D.	Division of Rheumatology, Department of Internal Medicine, Asan Medical Center, University of Ulsan
Young Bin Joo, M.D., Ph.D.	Internal Medicine, Hanyang University, Guri, Korea
Insoo Kang, M.D.	Internal Medicine, Yale University, Connecticut, USA
Ji-Hyoun Kang, M.D., Ph.D.	Internal Medicine, Chonnam National University, Gwangju, Korea
Ji Yeon Lee, M.D., Ph.D.	Internal Medicine, The Catholic University of Korea, Seoul, Korea
Kwanghoon Lee, M.D., Ph.D.	Internal Medicine, Dongguk University, Ilsan, Korea
Kyung-Ann Lee, M.D., Ph.D.	Internal Medicine, Soonchunhyang University, Seoul, Korea
Soo-Young Lee, M.D., Ph.D.	Pediatrics, The Catholic University of Korea, Seoul, Korea
Ki Won Moon, M.D., Ph.D.	Internal Medicine, Kangwon National University, Chuncheon, Korea
Evgeny Nasonov, M.D., Ph.D.	Internal Medicine, Nasonova Institute of Rheumatology, Moscow, Russia
Swapan K. Nath, Ph.D.	Pediatrics and Pathology, Oklahoma Medical Research Foundation, Oklahoma, USA
Jun Won Park, M.D., Ph.D.	Division of Rheumatology, Department of Internal Medicine, Seoul National University, Seoul, Korea
Marta Alarcón Riquelme, M.D., Ph.D.	Internal Medicine, University of Granada, Granada, Spain
Nan Shen, M.D., Ph.D.	Rheumatology, Shangha Jiao Tong University, Shanghai, China
Jasvinder Singh, M.D., M.P.H.	Medicine and Epidemiology, University of Alabamaat Birmingham, Alabama, USA
Chang-Youh Tsai, M.D., Ph.D.	Immunology and Rheumatology, Taipei Veterans General Hospital, Taipei City, Taipei
Betty Tsao, Ph.D.	Internal Medicine, Medical University of South Carolina, South Carolina, USA
Xiaofeng Zeng, M.D	Immunology and Rheumatology, Peking Union Medical College, Beijing, China

Manuscript Editor

Manuscript Editor
So Yeon Cho	MEDrang inc.

Administrative Manager

Administrative Manager
Jae-Eun Yu	MEDrang inc.

Editorial Staff

Editorial Staff
Hyeon-Jeong Kim	Korean College of Rheumatology
Sodam Kwon	Korean College of Rheumatology

Editor-in-Chief

Editor-in-Chief
Seong-Kyu Kim, M.D., Ph.D.	Internal Medicine, Daegu Catholic University, Daegu, Korea

Deputy Editor

Deputy Editor
Soo-Kyung Cho, M.D., Ph.D.	Internal Medicine, Hanyang University, Seoul, Korea

Associate Editor

Associate Editor
Jong Gyun Ahn, M.D., Ph.D.	Pediatrics, Yonsei University, Seoul, Korea
Jae-Bum Jun, M.D., Ph.D.	Internal Medicine, Hanyang University, Seoul, Korea
Young Ho Lee, M.D., Ph.D.	Internal Medicine, Korea University, Seoul, Korea
Jin Kyun Park, M.D., Ph.D.	Internal Medicine, Seoul National University, Seoul, Korea
Min-Chan Park, M.D., Ph.D.	Internal Medicine, Yonsei University, Seoul, Korea

Ethics Editor

Ethics Editor
Im Hee Shin, Ph.D.	Medical Statistics, Daegu Catholic University, Daegu, Korea

Statistics Editor

Statistics Editor
Hyonggin An, Ph.D.	Biostatistics, Korea University, Seoul, Korea

Editorial Board

Editorial Board
Jong Gyun Ahn, M.D., Ph.D.	Pediatrics, Yonsei University, Seoul, Korea
Tatsuya Atsumi, M.D., Ph.D.	Rheumatology, Endocrinology and Nephrology, Hokkaido University, Sapporo, Japan
Matt Brown, M.D	Medical & Molecular Genetics, King’s College London, London, UK
Hyon K Choi, M.D.	Internal Medicine, Harvard Medical School, Massachusetts, USA
Robert D. Inman, B.A., M.D.	Immunology, Toronto University, Toronto, Canada
Seokchan Hong, M.D., Ph.D.	Division of Rheumatology, Department of Internal Medicine, Asan Medical Center, University of Ulsan
Ji Hyeon Ju, M.D., Ph.D.	Internal Medicine, The Catholic University of Korea, Seoul, Korea
Insoo Kang, M.D.	Internal Medicine, Yale University, Connecticut, USA
Bon San Koo, M.D., Ph.D.	Internal Medicine, Inje University, Seoul, Korea
Doo-Ho Lim, M.D., Ph.D.	Internal Medicine, University of Ulsan, Ulsan, Korea
Ki Won Moon, M.D., Ph.D.	Internal Medicine, Kangwon National University, Chuncheon, Korea
Evgeny Nasonov, M.D., Ph.D.	Internal Medicine, Nasonova Institute of Rheumatology, Moscow, Russia
Swapan K. Nath, Ph.D.	Pediatrics and Pathology, Oklahoma Medical Research Foundation, Oklahoma, USA
Jin Kyun Park, M.D., Ph.D.	Internal Medicine, Seoul National University, Seoul, Korea
Min-Chan Park, M.D., Ph.D.	Internal Medicine, Yonsei University, Seoul, Korea
Marta Alarcón Riquelme, M.D., Ph.D.	Internal Medicine, University of Granada, Granada, Spain
Nan Shen, M.D., Ph.D.	Rheumatology, Shangha Jiao Tong University, Shanghai, China
Jasvinder Singh, M.D., M.P.H.	Medicine and Epidemiology, University of Alabamaat Birmingham, Alabama, USA
Young Sun Suh, M.D., Ph.D.	Internal Medicine, Gyeongsang National University, Changwon, Korea
Chang-Youh Tsai, M.D., Ph.D.	Immunology and Rheumatology, Taipei Veterans General Hospital, Taipei City, Taipei
Betty Tsao, Ph.D.	Internal Medicine, Medical University of South Carolina, South Carolina, USA
Xiaofeng Zeng, M.D	Immunology and Rheumatology, Peking Union Medical College, Beijing, China

Manuscript Editor

Manuscript Editor
Hyun Ju Ha	MEDrang inc.

Administrative Manager

Administrative Manager
Jae-Eun Yu	MEDrang inc.

Editorial Staff

Editorial Staff
Hyeon-Jeong Kim	Korean College of Rheumatology
Jieun Ryu	Korean College of Rheumatology

Editor-in-Chief

Editor-in-Chief
Young Ho Lee, M.D., Ph.D.	Internal Medicine, Korea University, Seoul, Korea

Managing Editor

Managing Editor
Soo-Kyung Cho, M.D., Ph.D.	Internal Medicine, Hanyang University, Seoul, Korea
Yong-Gil Kim, M.D., Ph.D.	Internal Medicine, University of Ulsan, Seoul, Korea

Editorial Board

Editorial Board
Jong Gyun Ahn, M.D., Ph.D.	Pediatrics, Yonsei University, Seoul, Korea
Joong Kyong Ahn, M.D., Ph.D.	Internal Medicine, Sungkyunkwan University, Seoul, Korea
Tatsuya Atsumi, M.D., Ph.D.	Rheumatology, Endocrinology and Nephrology, Hokkaido University, Sapporo, Japan
Matt Brown, M.D	Medical & Molecular Genetics, King’s College London, London, UK
Hyon K Choi, M.D.	Internal Medicine, Harvard Medical School, Massachusetts, USA
Robert D. Inman, B.A., M.D.	Immunology, Toronto University, Toronto, Canada
Young Bin Joo, M.D., Ph.D.	Internal Medicine, Hanyang University, Guri, Korea
Insoo Kang, M.D.	Internal Medicine, Yale University, Connecticut, USA
Seong-Kyu Kim, M.D., Ph.D.	Internal Medicine, Daegu Catholic University, Daegu, Korea
Seoyoung Catherine Kim, M.D.	Epidemiology, Harvard Medical School, Massachusetts, USA
Tae-Jong Kim, M.D., Ph.D.	Internal Medicine, Chonnam National University, Gwangju, Korea
Bon San Koo, M.D., Ph.D.	Internal Medicine, Inje University, Seoul, Korea
Seung-Geun Lee, M.D., Ph.D.	Internal Medicine, Pusan National University, Busan, Korea
Doo-Ho Lim, M.D., Ph.D.	Internal Medicine, University of Ulsan, Ulsan, Korea
Evgeny Nasonov, M.D., Ph.D.	Internal Medicine, Nasonova Institute of Rheumatology, Moscow, Russia
Swapan K. Nath, Ph.D.	Pediatrics and Pathology, Oklahoma Medical Research Foundation, Oklahoma, USA
Jin Kyun Park, M.D., Ph.D.	Internal Medicine, Seoul National University, Seoul, Korea
Min-Chan Park, M.D., Ph.D.	Internal Medicine, Yonsei University, Seoul, Korea
Marta Alarcón Riquelme, M.D., Ph.D.	Internal Medicine, University of Granada, Granada, Spain
Nan Shen, M.D., Ph.D.	Rheumatology, Shangha Jiao Tong University, Shanghai, China
Jasvinder Singh, M.D., M.P.H.	Medicine and Epidemiology, University of Alabamaat Birmingham, Alabama, USA
Chang-Youh Tsai, M.D., Ph.D.	Immunology and Rheumatology, Taipei Veterans General Hospital, Taipei City, Taipei
Betty Tsao, Ph.D.	Internal Medicine, Medical University of South Carolina, South Carolina, USA
Xiaofeng Zeng, M.D	Immunology and Rheumatology, Peking Union Medical College, Beijing, China

Manuscript Editor

Manuscript Editor
Seokhyeon Kang	MEDrang inc.

Administrative Manager

Administrative Manager
Jae-Eun Yu	MEDrang inc.

Editorial Staff

Editorial Staff
Hyeon-Jeong Kim	Korean College of Rheumatology
Jieun Ryu	Korean College of Rheumatology

Oct 01, 2024 Vol.31 No.4, pp. 191~263

COVER PICTURE

Ancestry-driven pathways for SLE-risk SNP-associated genes. The ancestry-driven key signaling pathways in Asians, Europeans, and African Americans were analyzed by enrichr (https://maayanlab.cloud/Enrichr/#libraries) using non-HLA SNP-associated genes. SLE: systemic lupus erythematosus, SNP: single-nucleotide polymorphism, JAK–STAT: janus kinase–signal transducers and activators of transcription, IFN: interferon gamma. (J Rheum Dis 2024;31:200-211)

Current Issue Archives

Most Keyword ?
What is Most Keyword?

It is most registrated keyword in articles at this journal during for 2 years.

Most Cited

Disentangling Diagnosis and Management of Fibromyalgia

Ji-Hyoun Kang, M.D., Ph.D., Sung-Eun Choi, M.D., Dong-Jin Park, M.D., Ph.D., Shin-Seok Lee, M.D., Ph.D.
J Rheum Dis 2022;29: 4-13
The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout

Seong-Kyu Kim, M.D., Ph.D.
J Rheum Dis 2022;29: 140-153

Editorial Office

_{Schematic structure of NLRP3 inflammasome complex. The NLRP3 inflammasome complex consists of the NLRP3 scaffold, the ASC adaptor, and pro-caspase-1 proteins. Deletion of the CARD domain and activation of caspase-1 domain of pro-caspase-1 leads to formation of active caspase-1, then resulting in cleavage from pro-IL-1β to IL-1β. ASC: apoptosis-associated speck-like protein, CARD: caspase activation and recruitment domain, IL: interleukin, LRR: leucine-rich repeat, NACHT: neuronal apoptosis inhibitory protein (NAIP), MHC class II transcription activator (CIITA), incompatibility locus protein from Podospora anserina (HET-E), and telomerase-associated protein (TP1), NLRP3: NACHT, LRR, and PYD domains-containing protein 3, PYD: pyrin domain.}|@|~(^,^)~|@|_{Signal pathway for NLRP3 inflammasome activation. Activation of the NLRP3 inflammasome is essential for two steps such as priming (signal 1) and activation (signal 2). In priming step, activation of TLR or TNFR after exposure of danger signals facilitates NF-κB signaling pathway for initiating transcription and production of precursor of pro-inflammatory cytokine including pro-IL-1β and pro-IL-18. Next, sensing PAMPs or DAMPs triggers NLRP3 oligomerization and ASC and pro-caspase-1 recruitment (signal 2). Autocleavage and activation of caspase-1 results in maturation and release of pro-inflammatory cytokines IL-1β and IL-18. PAMPs: pathogen-associated molecular patterns, DAMPs: damage-associated molecular patterns, ASC: apoptosis-associated speck-like protein, CARD: caspase activation and recruitment domain, TLR: toll-like receptor, TNFR: tumor necrosis factor receptor, ROS: reactive oxygen species, IKK: IκB kinase, IL: interleukin, NF-κB: nuclear factor-κB, NACHT: neuronal apoptosis inhibitory protein (NAIP), MHC class II transcription activator (CIITA), incompatibility locus protein from Podospora anserina (HET-E), and telomerase-associated protein (TP1), NLRP3: NACHT, LRR, and PYD domains-containing protein 3.}|@|~(^,^)~|@|_{Mechanism for IL-1β/IL-1R-related inflammatory signaling pathway. IL-1β/IL-1R complex is generated by the heterodimer signaling receptors and cytokine. The TIR domain, an intercellular signaling protein motif between receptors and adaptors, associates with adaptor MyD88, thus resulting in recruitment of IRAK and dimerized TRAF6. This subsequently activates multiple downstream signaling pathways including IκB-kinase complex and MAPK. Activation of transcription factors including NF-κB and AP-1 results in diverse pro-inflammatory cytokines and chemokines. IL-1β: interleukin-1β, IL-1RI: interleukin-1 receptor type I, TIR: toll/interleukin-1 receptor, MyD88: myeloid differentiation primary response 88, IRAK: interleukin-1 receptor associated kinase, TRAF6: TNF receptor-associated factor 6, TNF: tumor necrosis factor, NF-κB: nuclear factor-κB.}

J Rheum Dis 2022;29:140~153 https://doi.org/10.4078/jrd.2022.29.3.140

Editorial Board

Editor-in-Chief

Deputy Editor

Associate Editor

Ethics Editor

Statistics Editor

Editorial Board

Manuscript Editor

Administrative Manager

Editorial Staff

Editor-in-Chief

Deputy Editor

Associate Editor

Ethics Editor

Statistics Editor

Editorial Board

Manuscript Editor

Administrative Manager

Editorial Staff

Editor-in-Chief

Managing Editor

Editorial Board

Manuscript Editor

Administrative Manager

Editorial Staff

Most Keyword ? What is Most Keyword? It is most registrated keyword in articles at this journal during for 2 years.

What is Most Keyword?

Most Read

Disentangling Diagnosis and Management of Fibromyalgia

Juvenile Dermatomyositis

Most Cited

Disentangling Diagnosis and Management of Fibromyalgia

The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout

Editorial Office

Most Keyword ?
What is Most Keyword?

It is most registrated keyword in articles at this journal during for 2 years.